Drug Recalls

Voluntary Recall: Two Lots of NP Thyroid® Tablets, Due to Sub Potency

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency

Date of Release: Sept. 18, 2020 

ATLANTA /PRNewswire/ — Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has found these lots to be sub potent. The product may have as low as 87% of the labeled amount of levothyroxine (T4). More information can be found at www.npthyroid.com/product-updates.

Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive sub potent NP Thyroid®, may experience signs and symptoms of hypothyroidism (underactive thyroid) which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight. There is reasonable risk of serious injury in newborn infants or pregnant women with hypothyroidism including early miscarriage, fetal hyperthyroidism, and/or impairments to fetal neural and skeletal development. In elderly patients and patients with underlying cardiac disease toxic cardiac manifestations of hyperthyroidism may occur, such as cardiac pain, palpitations or cardiac arrhythmia. To date, Acella has received four reports of adverse events for these lot numbers possibly related to this recall.

NP Thyroid®, Thyroid Tablets, USP is composed of levothyroxine and liothyronine, and used to treat hypothyroidism (underactive thyroid). The products subject to recall are packed in 100-count bottles. See product images.

To best identify the product, the NDC’s, Product Description, Lot Numbers and Expiration Dates are listed. These lots were distributed nationwide in the USA to Acella’s direct accounts, including wholesalers, pharmacies, and healthcare offices. Additionally, consumers may be able to determine that their product is not impacted by the recall if the “use by,” “discard after,” or “expiration date” on their prescription bottle is on or after December 2020.

Product NDCLot #Exp. Date
NP Thyroid® 15, Thyroid Tablets, USP,¼ grain (15 mg)42192-327-01M327E19-1October 2020
NP Thyroid® 120, Thyroid Tablets, USP,2 grain (120 mg)42192-328-01M328F19-3November 2020

See Product Labels:

Acella is proactively notifying its wholesalers by email and phone to discontinue distribution of the two above referenced lots being recalled and is arranging for return of all recalled products. Patients who are currently taking NP Thyroid® from the lots being recalled should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription.

Consumers with questions about the recall can email Acella Pharmaceuticals at recall@acellapharma.com or contact our representatives at 1-888-280-2044, Monday through Friday from 8:00 am to 5:00 pm ET. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse events or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

SOURCE Acella Pharmaceuticals

Medika Life

Medika Life is a digital Health Publication for both the medical profession and the public. Make informed decisions about your health and stay up to date with the latest developments and technological advances in the fields of medicine.

Recent Posts

AI-Powered Obesity Care: FlyteHealth Delivers Big Wins for Connecticut’s Public Employees

In an era where access to effective obesity care remains mired in controversy over medication…

16 hours ago

BIO – Biotech Without Borders

This year’s gathering in Boston—a city long synonymous with health innovation—welcomed more than 20,000 attendees…

1 day ago

Clinic Notes: I Didn’t Expect to Speak Japanese Today

He came in wearing a loose hospital gown, but he carried himself like a man…

1 day ago

Simple Isometric Exercises to Build Strength and Mental Wellness for All Ages

Isometric exercises are ideal for incorporating into your regular routines, as they involve engaging muscles without…

1 day ago

Blending Renaissance Thinking and Collaborative Power to Address Global Health Challenges

When I first encountered Yasushi Yamamoto—musician, philosopher, investor, and Founder and CEO of Corundum—I was…

1 week ago

The Number That Predicts How Fast You’re Aging

When I turned 50, I didn’t care how many birthdays I had left. I cared…

1 week ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More